Semnur Pharmaceuticals, Inc.
8,00 €
0,00 €
(0,00%)
Cap. Boursière: 1,84 B
Prix
8,00 €
Cap. Boursière
1,84 B
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—
Historique des Prix
Tendances Financières
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
Aucune estimation prévisionnelle disponible
No quarterly estimates available
No fundamental snapshot available yet.
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2022 | FY2023 |
|---|---|---|---|---|
| Revenue | — | 50,00 M | — | — |
| Net Income | -160,42 M | -167 306,0 | -419 390,0 | 632 536,0 |
| EPS (Diluted) | -0,78 | — | — | — |
| Gross Profit | — | — | — | — |
| Operating Income | -160,42 M | -1,65 M | — | — |
| EBITDA | — | — | — | — |
| R&D Expenses | 2,55 M | — | — | — |
| SG&A Expenses | — | — | — | — |
| D&A | — | — | — | — |
| Interest Expense | — | 96 242,0 | — | 36 909,0 |
| Income Tax | 0,0 | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2022 | FY2023 |
|---|---|---|---|---|
| Total Assets | 1,35 M | 9,04 M | 86,28 M | 50,69 M |
| Total Liabilities | 22,10 M | 10,43 M | 4,18 M | 8,49 M |
| Shareholders' Equity | -20,75 M | -10,42 M | -3,27 M | -8,28 M |
| Total Debt | — | — | — | — |
| Cash & Equivalents | 20 000,0 | — | — | 204 464,0 |
| Current Assets | 596 000,0 | 16 868,0 | 907 836,0 | 209 440,0 |
| Current Liabilities | 10,17 M | 7,55 M | 1,29 M | 5,60 M |
{"event":"ticker_viewed","properties":{"ticker":"SMNR","listing_kind":"stock","pathname":"/stocks/smnr","exchange":"OTC","country":"US"}}